Table 4 Clinicopathological features associated with survival outcomes of ASC
Characteristics | No. | RFS | P | OS | P | |
|---|---|---|---|---|---|---|
5-year rate (%) | 5-year rate (%) | |||||
Age | ≤40 | 22 | 78.0 | 0.374 | 80.0 | 0.459 |
>40 | 108 | 71.2 | Â | 73.6 | Â | |
FIGO Stage | IB | 86 | 77.6 | 0.035 | 81.0 | 0.013 |
IIA | 44 | 58.2 | Â | 62.0 | Â | |
Size | <4 cm | 85 | 75.5 | 0.413 | 77.5 | 0.282 |
≥4 cm | 45 | 66.8 |  | 69.6 |  | |
LNM | No | 95 | 81.7 | <0.001 | 84.4 | <0.001 |
Yes | 35 | 42.4 | Â | 47.8 | Â | |
LVSI | No | 61 | 76.9 | 0.156 | 77.6 | 0.453 |
Yes | 69 | 71.3 | Â | 72.0 | Â | |
DSI | <1/2 | 60 | 81.3 | 0.039 | 83.2 | 0.012 |
≥1/2 | 70 | 63.7 |  | 65.1 |  | |
SCC-Ag | ≤5 ng/ml | 118 | 72.8 | 0.595 | 75.8 | 0.291 |
>5 ng/ml | 12 | 62.6 |  | 64.2 |  | |
CEA | ≤5 ng/ml | 86 | 75.9 | 0.441 | 77.4 | 0.205 |
>5 ng/ml | 44 | 67.1 |  | 69.0 |  | |
CA 19–9 | ≤37 U/ml | 113 | 71.6 | 0.536 | 74.5 | 0.886 |
>37 U/ml | 17 | 72.5 |  | 75.3 |  | |
CA 125 | ≤35 U/ml | 98 | 72.4 | 0.256 | 78.5 | 0.070 |
>35 U/ml | 32 | 60.7 |  | 62.2 |  | |